Max Backman
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 8
- Cancer Cells and Metastasis 3
-
- Lung Cancer Treatments and Mutations 5
- Infection Control and Ventilation 1
- Co-authors
- Patrick Micke (18 shared papers)Dijana Djureinovic (4 shared papers)Artur Mezheyeuski (9 shared papers)Hans Brunnström (12 shared papers)Annika Smeds (1 shared paper)Rainer Sjöholm (1 shared paper)Patrik Eklund (1 shared paper)L. Krönberg (1 shared paper)
In The Last Decade
Max Backman
22 papers receiving 747 citations
Peers
Comparison fields: 5 of 85
- Oncology 317
- Biochemistry 45
- Cancer Research 94
- Immunology 129
- Pulmonary and Respiratory Medicine 128
Countries citing papers authored by Max Backman
This map shows the geographic impact of Max Backman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Backman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Backman more than expected).
Fields of papers citing papers by Max Backman
This network shows the impact of papers produced by Max Backman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Backman. The network helps show where Max Backman may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Backman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 163 | |
| 2 | 2017 | 147 | |
| 3 | 2007 | 147 | |
| 4 | 2022 | 47 | |
| 5 | 2021 | 37 | |
| 6 | 2021 | 34 | |
| 7 | 2023 | 28 | |
| 8 | 2021 | 27 | |
| 9 | 2019 | 22 | |
| 10 | 2020 | 19 | |
| 11 | 2007 | 18 | |
| 12 | 2021 | 18 | |
| 13 | 2004 | 13 | |
| 14 | 2023 | 11 | |
| 15 | 2020 | 11 | |
| 16 | 2020 | 7 | |
| 17 | 2025 | 6 | |
| 18 | 2023 | 3 | |
| 19 | 2017 | 2 | |
| 20 | 2021 | 1 |
About Max Backman
Max Backman is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 24 papers that have together received 763 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (5 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Cells and Metastasis (3 papers), Cancer Genomics and Diagnostics (2 papers), Immune cells in cancer (2 papers), Infection Control and Ventilation (1 paper) and Radiomics and Machine Learning in Medical Imaging (1 paper). The work is most often cited by research in Oncology (317 citations), Biochemistry (45 citations), Cancer Research (94 citations), Immunology (129 citations) and Pulmonary and Respiratory Medicine (128 citations). Max Backman has collaborated with scholars based in Sweden, Norway and Germany. Frequent co-authors include Patrick Micke, Dijana Djureinovic, Artur Mezheyeuski, Hans Brunnström, Annika Smeds, Rainer Sjöholm, Patrik Eklund, L. Krönberg, Tobias Sjöblom and Miklós Gulyás. Their work appears in journals such as Lung Cancer, European Journal of Cancer, Journal for ImmunoTherapy of Cancer, Journal of Histochemistry & Cytochemistry and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.